![Doug Hubatsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Doug Hubatsch is currently Chief Scientific Officer & Executive VP at Nicox SA since 2021.
Formerly, Mr. Hubatsch was Global Head-Ocular Surface Diseases at Novartis Pharmaceuticals.
Postes actifs de Doug Hubatsch
| Sociétés | Poste | Début |
|---|---|---|
| NICOX SA | Directeur Technique/Scientifique/R&D | 13/12/2021 |
Anciens postes connus de Doug Hubatsch
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
